AtriCure (ATRC) Payables (2010 - 2026)

AtriCure (ATRC) has 17 years of Payables data on file, last reported at $30.6 million in Q1 2026.

• Payables for Q1 2026 came in at $30.6 million, up 21.38% year-over-year; the trailing twelve-month figure through Mar 2026 was $30.6 million (up 21.38% YoY), and the FY2025 annual result was $25.3 million, up 1.11% from the prior year.
• Payables grew to $30.6 million in Q1 2026 per ATRC's latest filing, from $25.3 million in the prior quarter.
• Over five years, Payables peaked at $31.7 million in Q3 2024 and troughed at $19.9 million in Q4 2022.
• A 5-year average of $25.4 million and a median of $25.2 million in 2025 frame the typical range for Payables.
• The sharpest annual moves came in 2022 and 2025: Payables soared 43.8% in 2022, then dropped 19.74% in 2025.
• A 5-year view of Payables shows it stood at $19.9 million in 2022, then jumped by 37.47% to $27.4 million in 2023, then retreated by 8.49% to $25.0 million in 2024, then climbed by 1.11% to $25.3 million in 2025, then advanced by 20.73% to $30.6 million in 2026.
• Business Quant data shows ATRC's Payables at $30.6 million in Q1 2026, $25.3 million in Q4 2025, and $25.5 million in Q3 2025.